Verification of breath-hold technique in stereotactic body radiotherapy for lung cancer: what are the optimal margins?

Verification of breath-hold technique in stereotactic body radiotherapy for lung cancer: what are the optimal margins? - Verification of breath-hold technique in stereotactic body radiotherapy for lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026080

Enrollment

Registered

2017-02-10

Start date

2015-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary stage I lung cancer or solitary metastatic lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) primary stage I lung cancer or 3 or less metastatic lung cancer 2) the target respiratory motion was 10 mm or more 3) capability of 15 seconds or more breath-hold following our sign 4) consent has been obtained from them

Exclusion criteria

Exclusion criteria: 1) arteriovenous fistulae of the lung 2) uncontrollable bleeding disorder 3) diagnosed psychiatric 4) pregnant

Design outcomes

Primary

Measure	Time frame
The reproducibility of breath-hold technique in stereotactic radiotherpay for lung cancer	—

Countries

Japan

Contacts

Public ContactTaro Murai

Nagoya City University Radiology

radon@med.nagoya-cu.ac.jp052-853-8276

Outcome results